Recent Posts

News, partners
Congenica announces partnership with Avesthagen
Posted 11th August 2022

Congenica announces partnership with Avesthagen

Read More
News , Blog , precision oncology
Collaborative development of novel Precision Oncology Solution
Posted 4th August 2022

Collaborative development of novel Precision Oncology Solution

Read More
News
Congenica appoints Robert Denison as CEO
Posted 22nd June 2022

Congenica appoints Robert Denison as CEO

Read More
News , award
Congenica wins Technology Company of the Year
Posted 12th May 2022

Congenica wins Technology Company of the Year

Read More
News
Congenica Appoints Dr. Tom Barber as Chief Scientific Officer
Posted 3rd May 2022

Congenica Appoints Dr. Tom Barber as Chief Scientific Officer

Read More
News
Congenica 为香港基因组计划提供全基因组测序三级数据分析
Posted 16th March 2022

Congenica 为香港基因组计划提供全基因组测序三级数据分析

Read More
News
Congenica to provide Tertiary Analysis for Whole Genome Sequencing for Hong Kong Genome Project
Posted 16th March 2022

Congenica to provide Tertiary Analysis for Whole Genome Sequencing for Hong Kong Genome Project

Read More
News , partners
Congenica and IAB Agree to Distribution Deal in Central Europe
Posted 27th January 2022

Congenica and IAB Agree to Distribution Deal in Central Europe

Read More
News
Congenica launches Comprehensive Genetic Carrier Screening at Arab Health 2022 
Posted 24th January 2022

Congenica launches Comprehensive Genetic Carrier Screening at Arab Health 2022 

Read More
News
Congenica Expands its Clinical Consulting Services
Posted 13th January 2022

Congenica Expands its Clinical Consulting Services

Read More
News , RareDiseases , GenomicsEngland
Congenica named as genomic analysis platform in ‘Impact of the 100,000 Genomes Pilot – Preliminary Report’ in the New England Journal of Medicine
Posted 11th November 2021

Congenica named as genomic analysis platform in ‘Impact of the 100,000 Genomes Pilot – Preliminary Report’ in the New England Journal of Medicine

Read More
1 2 3 4 5
... 11 next
News , partners
Congenica announces partnership with Avesthagen
Posted 11th August 2022

Congenica announces partnership with Avesthagen

Read More
News , Blog , precision oncology
Collaborative development of novel Precision Oncology Solution
Posted August Aug 4th 2022

Collaborative development of novel Precision Oncology Solution

Read More
News
Congenica appoints Robert Denison as CEO
Posted June Jun 22nd 2022

Congenica appoints Robert Denison as CEO

Read More
News , award
Congenica wins Technology Company of the Year
Posted May May 12th 2022

Congenica wins Technology Company of the Year

Read More
News
Congenica Appoints Dr. Tom Barber as Chief Scientific Officer
Posted May May 3rd 2022

Congenica Appoints Dr. Tom Barber as Chief Scientific Officer

Read More
News
Congenica 为香港基因组计划提供全基因组测序三级数据分析
Posted March Mar 16th 2022

Congenica 为香港基因组计划提供全基因组测序三级数据分析

Read More
News
Congenica to provide Tertiary Analysis for Whole Genome Sequencing for Hong Kong Genome Project
Posted March Mar 16th 2022

Congenica to provide Tertiary Analysis for Whole Genome Sequencing for Hong Kong Genome Project

Read More
News , partners
Congenica and IAB Agree to Distribution Deal in Central Europe
Posted January Jan 27th 2022

Congenica and IAB Agree to Distribution Deal in Central Europe

Read More
News
Congenica launches Comprehensive Genetic Carrier Screening at Arab Health 2022 
Posted January Jan 24th 2022

Congenica launches Comprehensive Genetic Carrier Screening at Arab Health 2022 

Read More
News
Congenica Expands its Clinical Consulting Services
Posted January Jan 13th 2022

Congenica Expands its Clinical Consulting Services

Read More
News , RareDiseases , GenomicsEngland
Congenica named as genomic analysis platform in ‘Impact of the 100,000 Genomes Pilot – Preliminary Report’ in the New England Journal of Medicine
Posted November Nov 11th 2021

Congenica named as genomic analysis platform in ‘Impact of the 100,000 Genomes Pilot – Preliminary Report’ in the New England Journal of Medicine

Read More
1 2 3 4 5
... 11 next
CE 60px-Conformité_Européenne - WHITE27001 RGB Tick 60x60 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2022 Congenica Ltd. Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.